Top Markets
Coin of the day
Amplitude Surgical S.A. Amplitude Surgical S.A.

Amplitude Surgical S.A.

AMPLI
Rank in Stocks #15498
Amplitude Surgical S.A. specializes in the design, development, and... Amplitude Surgical S.A. specializes in the design, development, and commercialization of surgical solutions for orthopedics. Its comprehensive portfolio addresses both primary and revision procedures, targeting a variety of conditions affecting the hip, knee, and lower limbs, with a particular focus on foot and ankle pathologies. This includes a wide array of knee and hip prostheses, as well as specialized implants for the foot and ankle. Beyond implants, Amplitude Surgical offers advanced technological platforms like AMPLIVISION, a computer-aided surgical system; i.M.A.G.E., a customized, single-use instrumentation solution; and E.T.O.I.L.E., an innovative platform facilitating less-invasive anterior surgical approaches. The company also supplies the necessary instrumentation for implant fitting. Operating globally, its products reach approximately 30 countries through an extensive network of distributors and agents, serving patients, surgeons, and healthcare institutions. Established in 1997, Amplitude Surgical S.A. maintains its headquarters in Valence, France.
Share Price
$7.27
Last synced: 2025-10-24
Market Cap
$348.95M
Change (1 day)
0.07%
Change (1 year)
0.07%
Country
FR
Trade Amplitude Surgical S.A. (AMPLI)

Category

P/E ratio for Amplitude Surgical S.A. (AMPLI)
P/E ratio as of September 2026 TTM: 195.92
According to Amplitude Surgical S.A. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 195.92. At the end of 2023 the company had a P/E ratio of 4.06.
P/E ratio history for Amplitude Surgical S.A. from 2011 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 195.92 84.64%
2024 106.11 2,512.17%
2023 4.06 -113.18%
2022 -30.83 309.62%
2021 -7.53 44.23%
2020 -5.22 -51.90%
2019 -10.85 -30.23%
2018 -15.55 -10.26%
2017 -17.33 -102.47%
2016 702.88 -5,538.01%
2015 -12.93 -76.94%
2014 -56.05 -24.49%
2013 -74.23 -6.14%
2012 -79.09 12.35%
2011 -70.40 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
42.58 -78.27%
US
29.69 -84.84%
FR
- -
JP
56.66 -71.08%
US
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.